Oral steroids for nasal polyps - PubMed (original) (raw)
Review
Oral steroids for nasal polyps
S Patiar et al. Cochrane Database Syst Rev. 2007.
Update in
- Oral steroids for nasal polyps.
Martinez-Devesa P, Patiar S. Martinez-Devesa P, et al. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD005232. doi: 10.1002/14651858.CD005232.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735400 Updated. Review.
Abstract
Background: Benign nasal polyps are lesions that arise from the mucosa of the nasal cavity or one or more of the nasal sinuses. The presenting symptoms of nasal polyps are nasal obstruction, watery anterior rhinorrhoea (excessive nasal secretions) or mucopurulent postnasal drip (or both), hyposmia and anosmia (reduced or absent sense of smell) with a concomitant alteration in taste and infrequently pain over the dorsum of the nose, forehead and cheeks. The main aim of treatment is to relieve these symptoms. Because of their uncertain aetiology treatment options differ, consisting of a combination of medical and surgical management. Medical therapy is mainly in the form of steroids, administered topically or systemically via the oral route.
Objectives: To assess the effects of oral steroids in patients with multiple nasal polyps.
Search strategy: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 1, 2006), MEDLINE (January 1950 to April 2006), EMBASE (January 1974 to April 2006), CINAHL, LILACS, MEDCARIB, KOREAMED, INDMED, PAKMEDINET, SAMED, PANTELEIMON, ZETOC, Cambridge Scientific Abstracts, mRCT (metaRegister of Clinical Trials), NRR (National Research Register), ISI Web of Science and the reference lists of relevant articles. We also contacted leading experts in the field. The date of the most recent search was April 2006.
Selection criteria: Randomised controlled trials and controlled clinical trials comparing oral steroids with no intervention, or placebo, or comparing doses or schedules of oral steroids in patients with multiple nasal polyps.
Data collection and analysis: Two authors independently extracted data and assessed study quality. Study authors were contacted for additional information.
Main results: Only one trial was identified which met the inclusion criteria. This trial showed a significant improvement in quality of life and nasal symptom scores (comprising nasal obstruction and loss of smell scores) and a significant reduction in polyp size after two weeks of treatment with oral steroids compared to no steroid treatment. However the trial was small and of low methodological quality.
Authors' conclusions: The authors found one small randomised controlled trial, albeit of poor quality, that suggests a short-term effect of oral steroids in patients with multiple nasal polyps. To address the issue more thoroughly a well designed, prospective randomised controlled trial is needed.
Similar articles
- Oral steroids for nasal polyps.
Martinez-Devesa P, Patiar S. Martinez-Devesa P, et al. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD005232. doi: 10.1002/14651858.CD005232.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735400 Updated. Review. - Short-course oral steroids alone for chronic rhinosinusitis.
Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Head K, et al. Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011991. doi: 10.1002/14651858.CD011991.pub2. Cochrane Database Syst Rev. 2016. PMID: 27113367 Free PMC article. Review. - Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps.
Rimmer J, Fokkens W, Chong LY, Hopkins C. Rimmer J, et al. Cochrane Database Syst Rev. 2014;2014(12):CD006991. doi: 10.1002/14651858.CD006991.pub2. Epub 2014 Dec 1. Cochrane Database Syst Rev. 2014. PMID: 25437000 Free PMC article. Review. - Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.
Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ. Head K, et al. Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011992. doi: 10.1002/14651858.CD011992.pub2. Cochrane Database Syst Rev. 2016. PMID: 27115214 Free PMC article. Review. - Topical steroids for nasal polyps.
Kalish L, Snidvongs K, Sivasubramaniam R, Cope D, Harvey RJ. Kalish L, et al. Cochrane Database Syst Rev. 2012 Dec 12;12:CD006549. doi: 10.1002/14651858.CD006549.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235631 Updated. Review.
Cited by
- Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
Beer H, Southern KW, Swift AC. Beer H, et al. Cochrane Database Syst Rev. 2015 Jun 22;2015(6):CD008253. doi: 10.1002/14651858.CD008253.pub4. Cochrane Database Syst Rev. 2015. PMID: 26098667 Free PMC article. Review. - Canadian guidelines for chronic rhinosinusitis: Clinical summary.
Kaplan A. Kaplan A. Can Fam Physician. 2013 Dec;59(12):1275-81, e528-34. Can Fam Physician. 2013. PMID: 24336538 Free PMC article. - Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches.
Kariyawasam HH, Scadding GK. Kariyawasam HH, et al. Allergy Asthma Immunol Res. 2011 Oct;3(4):226-35. doi: 10.4168/aair.2011.3.4.226. Epub 2011 Sep 1. Allergy Asthma Immunol Res. 2011. PMID: 21966602 Free PMC article. - Canadian clinical practice guidelines for acute and chronic rhinosinusitis.
Desrosiers M, Evans GA, Keith PK, Wright ED, Kaplan A, Bouchard J, Ciavarella A, Doyle PW, Javer AR, Leith ES, Mukherji A, Schellenberg RR, Small P, Witterick IJ. Desrosiers M, et al. Allergy Asthma Clin Immunol. 2011 Feb 10;7(1):2. doi: 10.1186/1710-1492-7-2. Allergy Asthma Clin Immunol. 2011. PMID: 21310056 Free PMC article. - A review of nasal polyposis.
Newton JR, Ah-See KW. Newton JR, et al. Ther Clin Risk Manag. 2008 Apr;4(2):507-12. doi: 10.2147/tcrm.s2379. Ther Clin Risk Manag. 2008. PMID: 18728843 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous